Spray drying has found widespread and in-depth application in the pharmaceutical and biopharmaceutical industries. It is no longer merely a simple drying tool but has evolved into a critical platform technology for particle engineering. From the solubilization of traditionally poorly soluble drugs to the stabilization of cutting-edge biomacromolecules, spray drying technology plays a crucial role.

Improving the bioavailability of poorly soluble drugs

Converting crystalline drugs into high-energy amorphous forms significantly improves solubility and absorption rates. The preparation of amorphous solid dispersions is one of the preferred technologies for addressing the challenges posed by approximately 40% of poorly soluble new molecular entities in the pharmaceutical industry today.

Stabilization of Biomacromolecules and Vaccine Innovation

During the drying process, heat-sensitive substances are protected through evaporative cooling and converted into dry powders that are stable at room temperature, eliminating the need for stringent cold-chain transportation and storage. This process is used to prepare inhalable protein/peptide drugs, thermostable vaccine powders, and mRNA drugs (while preserving their natural molecular structures).

Developing Advanced Drug Delivery Systems

Through "nano-micron" engineering strategies, the particle size, morphology, and internal structure are precisely controlled to enable targeted or controlled drug delivery. This approach involves formulating nano-carriers into inhalable dry powders for targeted pulmonary drug delivery, or preparing long-acting injectable microspheres to achieve sustained drug release over weeks or even months.

Meet the high-end production requirements for sterile formulations

This process converts solutions into sterile powders in a single step within a sealed, sterile environment, eliminating the risk of contamination associated with traditional freeze-drying methods that require subsequent grinding and repackaging. It is used to produce drugs with extremely stringent sterility requirements, such as sterile active pharmaceutical ingredients (APIs), injectable powders, antibodies, hormones, and blood products.

With the integration of cutting-edge technologies such as low-temperature spray drying, nano-spray drying, and 3D-printed microfluidics, spray drying is playing an increasingly vital role in broader fields such as precision medicine, complex formulations, and cell therapy.

In summary, spray drying technology is an indispensable key component of the modern pharmaceutical and biopharmaceutical industry chain. It bridges the gap between drug molecules and patient needs, continuously breaking through the physical and biological barriers of drug delivery through precise particle design.